PHARMACEUTICAL REPRESENTATIVES IN ACADEMIC MEDICAL-CENTERS - INTERACTION WITH FACULTY AND HOUSESTAFF

被引:106
作者
LURIE, N
RICH, EC
SIMPSON, DE
MEYER, J
SCHIEDERMAYER, DL
GOODMAN, JL
MCKINNEY, WP
机构
[1] Medical College of Wisconsin (DES, DLS), Minneapolis, Minnesota, St. Paul
[2] University of Minnesota Hospital, Minneapolis
[3] St. Paul Ramsey Hospital, Milwaukee, Wisconsin
[4] Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota, 55415
[5] St. Paul, Minnesota
关键词
drug detailing; marketing; pharmaceutical advertising; pharmaceutical representatives;
D O I
10.1007/BF02600542
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To determine the nature, frequency and effects of internal medicine bousestaff and faculty contacts with pharmaceutical representatives (PRs). Design and setting: The authors surveyed internal medicine faculty at seven midwest teaching hospitals and housestaff from two of the teaching programs. The survey asked about type and frequency of contacts with PRs and behavior that might be related to these contacts. T-tests and logistic regression were used to estimate the relationship between reported physician contacts and behavioral changes. Participants: Two hundred forty faculty (78%) and 131 house officers (75%) responded to the survey. Results: Faculty and housestaff averaged 1.5 brief contacts per month with PRs. Housestaff averaged more than one meal/month at pharmaceutical company expense. Twenty-five percent of faculty and 32% of residents reported changing their practices at least once based on PR contact. Independent predictors of faculty change in practice were brief or extended conversations and free meals. Predictors of faculty requests for formulary addition were brief conversations and receipt of honoraria or research support. Only brief conversations independently predicted housestaff changes in practice. Conclusion: Academic housestaff and faculty have frequent PR contact; such contact is related to changes in behavior. The potential for influence of PRs in academic medical centers should be recognized, and their activities should be evaluated accordingly. © 1990, Society of General Internal Medicine. All rights reserved.
引用
收藏
页码:240 / 243
页数:4
相关论文
共 13 条
[1]  
Young Q.D., Structural reforms in health care delivery, Arch Intern Med., 135, (1975)
[2]  
Miller R.R., Prescribing habits of physicians: a review of studies on prescribing of drugs, Drug Intell Clin Pharm., 8, pp. 81-91, (1974)
[3]  
Lexchin J., Pharmaceutical promotion in Canada, Int J Health Serv., 17, pp. 77-88, (1987)
[4]  
Worthen D.B., Prescribing influences: an overview, Br J Med. Educ., 7, (1973)
[5]  
Herman C.M., Rodowskas C.A., Communicating drug information to physicians, J Med Educ., 51, (1976)
[6]  
Eaton G., Parish P., Sources of drug information used by general practitioners. Prescribing in General Practice, J R Coll Gen. Pract., 26, pp. 58-64, (1976)
[7]  
Stross J.K., Information sources and clinical decisions, J Gen Intern Med., 2, (1987)
[8]  
Avorn J., Cehn M., Hartley R., Scientific versus commercial sources of influences on the prescribing behavior of physicians, Am J Med., 73, pp. 4-8, (1982)
[9]  
Hemminki E., Pesonen T., An inquiry into associations between leading physicians and the drug industry in Finland, Soc Sci Med., 11, (1977)
[10]  
Stross J.K., Hiss R.G., Watts C.M., Davis W.K., MacDonald R., Continuing education in pulmonary disease for primary physicians, Am Rev Resp Dis., 127, (1983)